Resminostat in combination with sorafenib second-line therapy of advanced hepatocellular carcinoma – The SHELTER Study

Bitzer, M; Horger, M; Giannini, E G; Ganten, T M; Worns, M A; Siveke, J T; Dollinger, M M; Gerken, G; Scheulen, M E; Wege, H; Zagonel, V; Cillo, U; Trevisani, F; Santoro, A; Montesarchio, V; Malek, N P; Holzapfel, J; Herz, T; Ammendola, A S; Pegoraro, S; Hauns, B; Mais, A; Lauer, U M; Henning, S W; Hentsch, B